Transgender (trans) communities in the USA and globally have long organized for health
and social equity but have only recently gained increased visibility within public health. In …

There is mounting evidence that lesbian, gay, bisexual, transgender, and queer or
questioning (LGBTQ) adults experience disparities across several cardiovascular risk factors …

Background Probability and nonprobability‐based studies of US transgender persons
identify different disparities in health and health care access. Objectives We used TransPop …

AIM: The “2024 Guideline for the Primary Prevention of Stroke” replaces the 2014
“Guidelines for the Primary Prevention of Stroke.” This updated guideline is intended to be a …

Objective Hormone therapy in transgender people might be associated with an increased
risk of cardiovascular disease (CVD). We aimed to investigate whether the risk of CVD is …

Abstract Purpose of Review Cardiovascular disease (CVD) is the leading cause of mortality
and morbidity worldwide for both men and women. However, CVD is understudied …

Cardiovascular disease (CVD) remains the leading cause of death in women in the United
States and globally, with heart disease actually on the rise among middle-aged women in …

Importance Little is known about the neurologic health needs of sexual and gender minority
(SGM) individuals, and existing research indicates health care disparities for this group …

Gender affirming hormone therapy (GAHT) is used by many transgender people to reduce
gender incongruence and improve psychological functioning. As GAHT shares many …

Introduction The objective of this research is to provide national estimates of the prevalence
of health condition diagnoses among age-entitled transgender and cisgender Medicare …